Loss of JAK1 Function Causes G2-M Cell-Cycle Defects Vulnerable to KIF18A Inhibition. Kelley VM, Baro M, Gasperi WE, Ader NR, et al. Cancer Res 2026;86:2301-2317.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kelley VM, Baro M, Gasperi WE, Ader NR, et al. Loss of JAK1 Function Causes G2-M Cell-Cycle Defects Vulnerable to KIF18A Inhibition. Cancer Res 2026;86:2301-2317.
PMID: 41591363